Additionally it should be noted that there is evidence that some gain-of-function (GOF) TP53 mutations (including R175H and R273H common in people with LFS) have been shown to have tumour angiogenesis promoting activity [81, 82]. Here, TP53 is linked to Li-Fraumeni syndrome.